DE69619116D1 - Endothelinrezeptorantagonisten - Google Patents

Endothelinrezeptorantagonisten

Info

Publication number
DE69619116D1
DE69619116D1 DE69619116T DE69619116T DE69619116D1 DE 69619116 D1 DE69619116 D1 DE 69619116D1 DE 69619116 T DE69619116 T DE 69619116T DE 69619116 T DE69619116 T DE 69619116T DE 69619116 D1 DE69619116 D1 DE 69619116D1
Authority
DE
Germany
Prior art keywords
endothelin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69619116T
Other languages
English (en)
Other versions
DE69619116T2 (de
Inventor
Juan Ignacio Luengo
Duncan Elliott
Jia-Ning Xiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE69619116D1 publication Critical patent/DE69619116D1/de
Publication of DE69619116T2 publication Critical patent/DE69619116T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE69619116T 1995-08-02 1996-08-02 Endothelinrezeptorantagonisten Expired - Fee Related DE69619116T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US179295P 1995-08-02 1995-08-02
US1098296P 1996-02-01 1996-02-01
PCT/US1996/012661 WO1997004773A1 (en) 1995-08-02 1996-08-02 Endothelin receptor antagonists

Publications (2)

Publication Number Publication Date
DE69619116D1 true DE69619116D1 (de) 2002-03-21
DE69619116T2 DE69619116T2 (de) 2002-09-19

Family

ID=26669471

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69636597T Expired - Fee Related DE69636597T2 (de) 1995-08-02 1996-08-02 Endothelin rezeptor antagonisten
DE69619116T Expired - Fee Related DE69619116T2 (de) 1995-08-02 1996-08-02 Endothelinrezeptorantagonisten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69636597T Expired - Fee Related DE69636597T2 (de) 1995-08-02 1996-08-02 Endothelin rezeptor antagonisten

Country Status (25)

Country Link
US (5) US5969151A (de)
EP (2) EP0843551B1 (de)
JP (2) JPH11511133A (de)
KR (1) KR19990036032A (de)
CN (1) CN1196680A (de)
AP (1) AP9801182A0 (de)
AT (1) ATE341324T1 (de)
AU (2) AU717172B2 (de)
BG (1) BG102229A (de)
BR (1) BR9609914A (de)
CA (2) CA2228296A1 (de)
CZ (1) CZ30498A3 (de)
DE (2) DE69636597T2 (de)
EA (1) EA000952B1 (de)
ES (2) ES2273350T3 (de)
HU (1) HU220776B1 (de)
MX (1) MX9800975A (de)
NO (1) NO980422L (de)
NZ (1) NZ315846A (de)
OA (1) OA10755A (de)
PL (1) PL184272B1 (de)
RO (1) RO115802B1 (de)
SK (1) SK282584B6 (de)
TR (1) TR199800152T1 (de)
WO (2) WO1997004772A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5021171A1 (es) * 1997-12-08 2001-03-27 Smithkline Beechman Corp Sal de monoargininilo del acido(e)-3-(1-n-butil-5-(2-(2- carboxifenil)metoxi-4-clorofenil)-1h-pirazol-4-il)-2- ((5-metoxi-2,3-dihidrobenzofuran-5-il)metil)-prop-2-enoico
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
US7087630B2 (en) * 2002-06-27 2006-08-08 Nitromed, Inc. Cyclooxygenase 2 selective inhibitors, compositions and methods of use
WO2006075955A1 (en) * 2005-01-13 2006-07-20 Astrazeneca Ab Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease
US7521435B2 (en) * 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
US8012038B1 (en) 2008-12-11 2011-09-06 Taylor Made Golf Company, Inc. Golf club head
US10086240B1 (en) 2015-08-14 2018-10-02 Taylor Made Golf Company, Inc. Golf club head
US10626096B2 (en) 2015-11-24 2020-04-21 Sanford Burnham Prebys Medical Discovery Institute Azole derivatives as apelin receptor agonist
US10773135B1 (en) 2019-08-28 2020-09-15 Taylor Made Golf Company, Inc. Golf club head

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1937241A1 (de) * 1968-08-02 1970-02-19 Sumitomo Chemical Co 3,5-Dioxopyrazolidinderivate und Verfahren zu ihrer Herstellung
JPH01211582A (ja) * 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
EP0403158A3 (de) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-Alkensäuren
EP0563238B1 (de) * 1990-12-14 2002-05-22 Smithkline Beecham Corporation Imidazolyl-alkencarbonsäuren
FR2682379B1 (fr) * 1991-10-09 1994-02-11 Rhone Poulenc Agrochimie Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en) * 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
CN1049219C (zh) * 1993-08-18 2000-02-09 万有制药株式会社 具有内皮素拮抗活性的芳香杂环并环戊烯衍生物
IL111613A0 (en) * 1993-11-12 1995-01-24 Rhone Poulenc Rorer Ltd Substituted phenyl compounds, their preparation and pharmaceutical compositions containing them
WO1996007653A1 (en) * 1994-09-02 1996-03-14 Smithkline Beecham Corporation Endothelin receptor antagonists

Also Published As

Publication number Publication date
AP9801182A0 (en) 1998-01-31
DE69636597T2 (de) 2007-08-16
EP0843551B1 (de) 2002-02-06
PL184272B1 (pl) 2002-09-30
NO980422D0 (no) 1998-01-30
CA2228293A1 (en) 1997-02-13
RO115802B1 (ro) 2000-06-30
HUP9902817A2 (hu) 1999-12-28
BG102229A (en) 1998-09-30
AU717172B2 (en) 2000-03-16
EP0843551A4 (de) 1998-08-12
ES2273350T3 (es) 2007-05-01
SK11398A3 (en) 1998-07-08
HU220776B1 (hu) 2002-05-28
CA2228296A1 (en) 1997-02-13
DE69619116T2 (de) 2002-09-19
WO1997004773A1 (en) 1997-02-13
AU6646396A (en) 1997-02-26
KR19990036032A (ko) 1999-05-25
US20020072614A1 (en) 2002-06-13
HUP9902817A3 (en) 2001-03-28
EP0843551A1 (de) 1998-05-27
EP0841925A1 (de) 1998-05-20
US6482956B2 (en) 2002-11-19
PL324745A1 (en) 1998-06-08
JPH11511133A (ja) 1999-09-28
ATE341324T1 (de) 2006-10-15
EP0841925A4 (de) 2001-10-17
NZ315846A (en) 1999-01-28
WO1997004772A1 (en) 1997-02-13
TR199800152T1 (xx) 1998-05-21
US6096897A (en) 2000-08-01
SK282584B6 (sk) 2002-10-08
CZ30498A3 (cs) 1998-07-15
EP0841925B1 (de) 2006-10-04
US6353116B1 (en) 2002-03-05
DE69636597D1 (de) 2006-11-16
AU6764596A (en) 1997-02-26
EA199800185A1 (ru) 1998-10-29
ES2171697T3 (es) 2002-09-16
MX9800975A (es) 1998-04-30
NO980422L (no) 1998-03-24
BR9609914A (pt) 1999-07-06
US5958968A (en) 1999-09-28
OA10755A (en) 2002-12-13
JP2001517195A (ja) 2001-10-02
EA000952B1 (ru) 2000-08-28
US5969151A (en) 1999-10-19
CN1196680A (zh) 1998-10-21

Similar Documents

Publication Publication Date Title
NO961072L (no) Endotelinreseptorantagonister
ATA135896A (de) Skibob
DE69619116D1 (de) Endothelinrezeptorantagonisten
NO963131D0 (no) Endotelinreseptorantagonister
NO963213D0 (no) Endotelinreseptorantagonister
DE69626986D1 (de) Endothelinrezeptorantagonist
ATE198470T1 (de) Alkenyl-benzoylguanidine
DE69628924D1 (de) Endothelinrezeptorantagonisten
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
BR9501643A (pt) Helistato
SE9501165D0 (sv) Hållaranordning
FI1968U1 (fi) Boejlig traetrall
KR960030307U (ko) 다시
BR7501299U (pt) Geladeira-prática
FIU950298U0 (fi) Tallrik
BR7500437U (pt) Girolight
BR7500703U (pt) Rodopratic
BR7500809U (pt) Tele-negocios
BR7500825U (pt) Chutegol
BR7501298U (pt) Torre-audio-visual
BR7500838U (pt) Vassourágua
BR7501301U (pt) Guarda-chuva-mochila
BR7501303U (pt) Dupla-embalagem
BR7501376U (pt) Massarreal

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee